undamentalytics Newsletter

Christianson Mark: insider trades

Officer at Neuroone Medical Technologies Corp. No open-market purchases and 10 sales not made under a pre-set plan, reported from June 16, 2020 to July 2, 2026.

What happened after Christianson Mark’s sales?

After their sales, the shares moved −77.0% against the index over 12 months on average (a negative figure means selling was the right call); 100% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

Trade by trade

Christianson Mark: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 0 — — — — — — Not enough years
Purchases, 6 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the trade 0 — — — — — — Not enough years
Sales, 3 months after the report 1 −44.3% −44.3% 100% 1 — — Not enough years
Sales, 12 months after the report 1 −77.0% −77.0% 100% 1 — — Not enough years
Sales, 12 months after the trade 1 −73.7% −73.7% 100% 1 — — Not enough years

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Neuroone Medical Technologies Corp NMTC Market Development Director010June 16, 2020July 2, 2026

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
July 2, 2026June 30, 2026 NMTC Sale $31,800 not yetnot yetnot yet
April 1, 2026March 30, 2026 NMTC Sale $11,369 not yetnot yetnot yet
March 12, 2026March 10, 2026 NMTC Sale $10,976 not yetnot yetnot yet
September 9, 2025September 5, 2025 NMTC Sale $22,200 not yetnot yetnot yet
June 7, 2024June 5, 2024 NMTC Sale $22,704 not yetnot yetnot yet
December 27, 2023December 26, 2023 NMTC Sale $55,154 not yetnot yetnot yet
December 26, 2023December 21, 2023 NMTC Sale $16,390 not yetnot yetnot yet
March 24, 2023March 21, 2023 NMTC Sale $40,079 not yetnot yetnot yet
June 25, 2021June 23, 2021 NMTC Sale $79,942 −44.3%−77.0%−73.7%
June 16, 2020June 12, 2020 NMTC Sale $200,400 not yetnot yetnot yet

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Christianson Mark traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.